Author

Faiz Zannad

Observed name: F ZANNAD ON BEHALF OF THE Vo2 FRENCH STUDY GROUP

Institutions: Inserm, Centre Hospitalier Régional et Universitaire de Nancy, Université de Lorraine

Observed institutions: Inserm, Centre Hospitalier Régional et Universitaire de Nancy, Hôpital Jeanne d'Arc, Université de Lorraine

OpenAlex ID: A5016322884

A Systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: Rationale, Design, and Baseline Characteristics of BIOSTAT-CHF

2016 · Adriaan A. Voors, Stefan D. Anker, et al. · European Journal of Heart Failure · 205

Proteomic Diversity of High-Density Lipoprotein Explains its Association with Clinical Outcome in Patients with Heart Failure

2017 · Johanna Elisabeth Emmens, Donald J.L. Jones, et al. · European Journal of Heart Failure · 37

Can anaerobic threshold be used as an end-point for therapeutic trials in heart failure?

1994 · A. COHEN-SOLAL, J. F. AUPETIT, et al. · European Heart Journal · 27

Abstract 17295: Cardiovascular Biomarkers and Long-term Outcomes in Patients with Type 2 Diabetes Mellitus Treated with Alogiptin vs. Placebo in the EXAMINE Trial

2014 · David A Morrow, Christopher P Cannon, et al. · Circulation · 2

LATE-BREAKING ABSTRACT: Treatment of predominant central sleep apnoea with ASV in patients with chronic heart failure: SERVE-HF primary results

2015 · Martin Cowie, Holger Woehrle, et al. · 1

Right ventricular–pulmonary arterial coupling in a community-based cohort

2026 · H Holm, A Zaghi, et al. · European Heart Journal

Works count: 5

Citation count: 272

H-index: 3

I10-index: 3